Cargando…
Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma
BACKGROUND: Hypoxia is a common feature of solid tumors, including HCC. And hypoxia has been reported to play an important role in HCC progression. However, the potential mechanism of miRNAs in hypoxia mediating HCC progression still remains unclear. METHODS: The HCC cells were cultured in the atmos...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493986/ https://www.ncbi.nlm.nih.gov/pubmed/26126858 http://dx.doi.org/10.1186/s13046-015-0182-1 |
_version_ | 1782380009690759168 |
---|---|
author | Du, Chengli Weng, Xiaoyu Hu, Wendi Lv, Zhen Xiao, Heng Ding, Chaofeng Gyabaah, Owusu-anash K. Xie, Haiyang Zhou, Lin Wu, Jian Zheng, Shusen |
author_facet | Du, Chengli Weng, Xiaoyu Hu, Wendi Lv, Zhen Xiao, Heng Ding, Chaofeng Gyabaah, Owusu-anash K. Xie, Haiyang Zhou, Lin Wu, Jian Zheng, Shusen |
author_sort | Du, Chengli |
collection | PubMed |
description | BACKGROUND: Hypoxia is a common feature of solid tumors, including HCC. And hypoxia has been reported to play an important role in HCC progression. However, the potential mechanism of miRNAs in hypoxia mediating HCC progression still remains unclear. METHODS: The HCC cells were cultured in the atmosphere of 1 % oxygen to induce hypoxia. The microRNA microarray was employed to search for the hypoxia-inducible miRNAs. RT-PCR, western blot and immunohistochemistry were used to detect the RNA and protein levels. HUVEC were applied to explore the angiogenesis level. RESULTS: We found that miR-182 was upregulated in the hypoxia-based microarray. We then revealed that miR-182 was also significantly increased in the HCC tissues compared to the corresponding normal tissues. In vitro capilliary tube formation assays showed that the miR-182 promoted angiogenesis. RASA1 was demonstrated as the direct target of miR-182. In addition, the suppression of RASA1 phenocopied the pro-angiogenesis effects of miR-182. Besides, RASA1 was also decreased in the hypoxia HCC cells while the inhibition of miR-182 partially restored the level of RASA1. CONCLUSIONS: Our data showed that hypoxia regulated the expression of miR-182 and RASA1 to promote HCC angiogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-015-0182-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4493986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44939862015-07-08 Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma Du, Chengli Weng, Xiaoyu Hu, Wendi Lv, Zhen Xiao, Heng Ding, Chaofeng Gyabaah, Owusu-anash K. Xie, Haiyang Zhou, Lin Wu, Jian Zheng, Shusen J Exp Clin Cancer Res Research Article BACKGROUND: Hypoxia is a common feature of solid tumors, including HCC. And hypoxia has been reported to play an important role in HCC progression. However, the potential mechanism of miRNAs in hypoxia mediating HCC progression still remains unclear. METHODS: The HCC cells were cultured in the atmosphere of 1 % oxygen to induce hypoxia. The microRNA microarray was employed to search for the hypoxia-inducible miRNAs. RT-PCR, western blot and immunohistochemistry were used to detect the RNA and protein levels. HUVEC were applied to explore the angiogenesis level. RESULTS: We found that miR-182 was upregulated in the hypoxia-based microarray. We then revealed that miR-182 was also significantly increased in the HCC tissues compared to the corresponding normal tissues. In vitro capilliary tube formation assays showed that the miR-182 promoted angiogenesis. RASA1 was demonstrated as the direct target of miR-182. In addition, the suppression of RASA1 phenocopied the pro-angiogenesis effects of miR-182. Besides, RASA1 was also decreased in the hypoxia HCC cells while the inhibition of miR-182 partially restored the level of RASA1. CONCLUSIONS: Our data showed that hypoxia regulated the expression of miR-182 and RASA1 to promote HCC angiogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-015-0182-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-28 /pmc/articles/PMC4493986/ /pubmed/26126858 http://dx.doi.org/10.1186/s13046-015-0182-1 Text en © Du et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Du, Chengli Weng, Xiaoyu Hu, Wendi Lv, Zhen Xiao, Heng Ding, Chaofeng Gyabaah, Owusu-anash K. Xie, Haiyang Zhou, Lin Wu, Jian Zheng, Shusen Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma |
title | Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma |
title_full | Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma |
title_fullStr | Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma |
title_full_unstemmed | Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma |
title_short | Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma |
title_sort | hypoxia-inducible mir-182 promotes angiogenesis by targeting rasa1 in hepatocellular carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493986/ https://www.ncbi.nlm.nih.gov/pubmed/26126858 http://dx.doi.org/10.1186/s13046-015-0182-1 |
work_keys_str_mv | AT duchengli hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT wengxiaoyu hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT huwendi hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT lvzhen hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT xiaoheng hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT dingchaofeng hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT gyabaahowusuanashk hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT xiehaiyang hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT zhoulin hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT wujian hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma AT zhengshusen hypoxiainduciblemir182promotesangiogenesisbytargetingrasa1inhepatocellularcarcinoma |